169 related articles for article (PubMed ID: 19077004)
1. Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma.
Okuno T; Ueda M; Tsuruyama T; Haga H; Takada Y; Maetani Y; Tamaki K; Manabe T; Tanaka K; Uemoto S
Cancer Sci; 2009 Mar; 100(3):520-8. PubMed ID: 19077004
[TBL] [Abstract][Full Text] [Related]
2. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
4. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
Li S; Wang H; Zhang C
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
[TBL] [Abstract][Full Text] [Related]
5. The association of frequent allelic loss on 17p13.1 with early metastatic recurrence of hepatocellular carcinoma after liver transplantation.
Zhou L; Zhou W; Wu L; Yu X; Xing C; Zheng S
J Surg Oncol; 2010 Dec; 102(7):802-8. PubMed ID: 20886556
[TBL] [Abstract][Full Text] [Related]
6. [Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance].
Pang JZ; Qin LX; Wang QQ; Ren N; Sun BS; Lin GL; Ye QH; Liu YK; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):906-9. PubMed ID: 18171524
[TBL] [Abstract][Full Text] [Related]
7. Genetic classification of combined hepatocellular-cholangiocarcinoma.
Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
[TBL] [Abstract][Full Text] [Related]
8. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
[TBL] [Abstract][Full Text] [Related]
9. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
Peng SY; Ou YH; Chen WJ; Li HY; Liu SH; Pan HW; Lai PL; Jeng YM; Chen DC; Hsu HC
Int J Oncol; 2005 Apr; 26(4):1053-61. PubMed ID: 15754002
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between nm23-H1 loss of heterozygosity and metastasis in hepatocellular carcinoma].
Ye Y; Yu Y; Wan D; Tang Z; Lu J; He L
Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):161-3. PubMed ID: 11825358
[TBL] [Abstract][Full Text] [Related]
13. Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma.
Lu T; Hano H
Liver Int; 2007 Aug; 27(6):782-90. PubMed ID: 17617121
[TBL] [Abstract][Full Text] [Related]
14. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
Shao J; Li X; Liu Z
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
[TBL] [Abstract][Full Text] [Related]
16. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
17. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
[TBL] [Abstract][Full Text] [Related]
18. [Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].
Zhao X; Wan D; Jiang H
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):377-80. PubMed ID: 11778272
[TBL] [Abstract][Full Text] [Related]
19. [Features of micro satellite alterations on chromosome 4 in hepatocellular carcinoma].
Zhang SH; Cong WM; Xian ZH; Wu MC
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):223-6. PubMed ID: 15099473
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
